SOURCE: SinoFresh Healthcare, Inc.

SinoFresh HealthCare, Inc.

December 01, 2009 09:20 ET

Successful Re-Launch of SinoFresh Nasal Spray Continues

VENICE, FL--(Marketwire - December 1, 2009) - SinoFresh Healthcare, Inc. (PINKSHEETS: SFSH) over the last six months has re-launched sales and distribution of the Sinofresh Nasal Spray product through the exclusive licensee of the products through, Sinofresh Healthcare Products, Inc., a privately held company. It was recently announced that a pilot animal study commissioned by the licensee has achieved positive results against H1N1 (Swine flu) virus using SinoFresh Nasal Spray. The following initiatives by the licensee, Sinofresh Healthcare Products, Inc., have been on going aside from the testing of the product:

    1. Launch of, to enhance marketing and
       distribution for SinoFresh Homeopathic Antiseptic Nasal Spray.
       The web based network of additional affiliated websites promoting
       the SinoFresh product line will substantially expand the ability
       to make sinus sufferers aware of SinoFresh Spray's benefits and
       enable individuals to obtain the product outside of our current
       regional U.S. test markets and distribution base in Florida and
       parts of the Northeast.  This product and a planned series of
       follow-on products built on the Company's proprietary technology
       will, in time, exploit an enormous global opportunity for the
       SinoFresh product line as people begin to understand the benefit
       of using a daily preventative that can actually kill the
       micro-organisms that cause of diseases in the upper respiratory

    2. The fall and winter media campaign for SinoFresh Antiseptic Nasal
       Spray, which coincides with the onset of the cold and flu season,
       has been initiated through WENG radio, broadcasting from
       Englewood, Florida, WFLA radio broadcasting from Tampa, FL with
       endorsement by morning radio host, Tedd Web and via the Internet.
       In addition to traditional ads, the  licensee is sponsoring a new
       program, "Medical Mondays," which aired for the first time on
       October 19, 2009, at 10:00AM, featuring  Senior Medical Advisor,
       Dr. Michael Stampar. Further radio and television advertising is
       being launched throughout Florida and around the country as part
       of the expanding advertising campaign.

    3. The introduction of a convenient 10 Unit retail counter display
       pack the novel, patented SinoFresh Homeopathic Nasal Spray. The
       new 10 Unit pack is has proven to be successful for independent
       pharmacies, chiropractors and Doctor's offices.  The 10 Unit
       display pack provides an attractive method for retailers to give
       greater customer visibility to SinoFresh Nasal Spray. This
       presentation more effectively helps introduce SinoFresh
       Homeopathic Nasal Spray to new customers as we are now into the
       cold and flu season, as well as addressing customers suffering
       from chronic sinusitis.

Charles Fust, CEO of SinoFresh Healthcare, Inc., says, "Use of SinoFresh Spray over the past 8 years has demonstrated it to be an effective solution for persons suffering from chronic sinusitis, a condition that affects 35 million Americans. We are pleased to be exclusively partnered with Sinofresh Healthcare Products, Inc. in the global distribution of the SinoFresh product line and support their ongoing efforts to build on a marketing theme of 'daily prevention' and the benefits of nasal cleansing in removing nasal pathogens in the upper respiratory tract. We believe we are on a track that could lead to the financial revitalization of the Company as the licensee continues to successfully move forward with their domestic and international marketing strategy."

About SinoFresh™ HealthCare, Inc.

SinoFresh™ HealthCare, Inc. is a developer of therapies to treat inflammatory and infectious diseases of the upper respiratory system which are marketed by Sinofresh Healthcare Products, Inc. a privately held company and exclusive licensee. The Company is committed to researching broad-spectrum antiseptic approaches to reducing viral, bacterial and fungal organisms suspected of causing pathogenesis of the mouth nose and throat. The Company holds certain patents and patent applications on its innovative pharmaceutical technology and relies upon a panel of medical experts and management team experienced in the bio-pharmaceutical industry.

The Company's flagship product, SinoFresh™ Nasal & Sinus Care, is the only homeopathic antiseptic nasal spray that in lab tests has been proven to kill bacteria, viruses, mold and fungi. More information is available at

*SinoFresh™ is a trademark of SinoFresh HealthCare, Inc.

The information in this press release may contain various forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 ("PSLRA") and which may be based on or include assumptions concerning the operations, future results and prospects of the Company. Such statements may be identified by the use of words like "plan," "expect," "aim," "believe," "project," "anticipate," "commit," "intend," "estimate," "will," "should," "could" and other expressions that indicate future events and trends.

All statements that address expectations or projections about the future, including without limitation, product development, product launches, regulatory approvals, market position, acquisitions, sale of assets, revenues, expenditures, resumption of manufacturing and distribution of products and other financial results, are forward-looking statements.

All forward-looking statements are based on current expectations only and are subject to risk and uncertainties. In connection with the "safe harbor" provisions, the Company provides the following cautionary statements identifying important economic, political and technological factors, which among others, could cause actual results or events to differ materially from those set forth or implied by the forward-looking statements and related assumptions.

For further information the company can be contacted at 941-375-8174, or on the web at, or by email at

Contact Information